Lisebelisoa tse ling tse sirelelitsoeng tsa Amono ea tlamo ea ho senya?
Lintlha tsa sehlahisoa
| NO | Lihlahisoa | Ha ho joalo | Kopo | Letšoao la boleng ba boleng | ||||
| Bohloeki | Isomer | Pholoso e ikhethileng | * Max1 | Mongobo | ||||
| 1 | Fmoc-cys (acm) -oh | 86080-81-3 | Botlamo ba ho senya | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 2 | Fmoc-CYS (MMT) -oh | 1775822-21-7 | Botlamo ba ho senya | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 3 | Fmoc-CYS (4-Allylbuteyrady) -oh | / | Botlamo ba ho senya | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 4 | MPA (TRT) --OTH | 27144-18-9 | Qetellong ea tatellano | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 5 | Fmoc-chre (tkhu) -ol | 189337-28-8-28-8 | Octreotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
| 6 | Fmoc-d-arg (pbf) -oh | 187618-60-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6- | Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
| 7 | Fmoc-gly-yly-oh | 35665-38-4 | Bivalrirudorin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 8 | Fmoc-gly-gly-oh | 170941-79-4 | Terlipresn | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 9 | Fmoc-gly-gly-gly-ah | / | Bivalrirudorin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 10 | Fmoc-gly-asp (tv (tv | / | Bivalrirudorin | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
| 11 | Boc-CYS (TRT) -OH | 21947-98-8 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 12 | Boc-Arg (PBF) -oh | 20024-22-7 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 13 | Boc-Ala-oh | 15761-38-3 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 14 | Boc-D-Pheh-oh | 18942-49-9 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 15 | Boc-gly-oh | 4530-20-5 | Qetellong ea tatellano | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 16 | Boc-lys (boc) -oh.hdcha | 15098-89 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 17 | Boc-ser (TJ) -oh | 7738-22-9 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 18 | Boc-Br (TB) -oh | 13734-40-20-2 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 19 | Boc-d-ala-oh | 7764-95-6-6-6-6-6-6 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 20 | Boc-Et-OH | 2488-15-5-5 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 21 | Boc-TYR (THAB) - | 47375-34-8 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 22 | Boc-D-Arg (PDF) -oh | 187618-60-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6-6- | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 23 | Boc-asp (Otbu) -oh.dcha | 1913/12/8 | Qetellong ea tatellano | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 24 | Fmoc-homoarg (pbf) -oh | 1159680-21-3 | Epfizatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
| 25 | Fmoc-asp-otbu | 129460-09-9 | Thricmalfasin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 26 | Fmoc-tyr (nna) -oh | 77128-72-4 | CarBerocin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 27 | Fmoc-orn (boc) -oh | 109425-5-0-0 | Atosiban Omnipresn Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
| 28 | Fmoc-d-thr (et) -oh | 162502-65-0-0 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 29 | Fmoc-asp (oall) -oh | 1469822-24-3 | Melanotan | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 30 | Ac-nle-oh | 15891-49-3 | Melanotan | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 31 | Fmoc-nle-oh | 77284-32-3 | Melanotan AfAmenotidede | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 32 | Ac-glu (Otbu) - | 84192-88-1 | Argireline Acetyl Octaperide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 33 | Ac-β-ala-oh | / | Acetyl Tetrapeptide-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
| 34 | Fmoc-ß-ala-oh | 35737-10-1 | Acetyl Tetrapeptide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 35 | Fmoc-hyp (tvo) -oh | 122996-47-8 | ITATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 36 | Fmoc-thi-oh | 130309-35-25-2 | ITATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 37 | Fmoc-d-timp-oh | 130309-33-0 | ITATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 38 | Fmoc-oic-oh | 130309-37-4 | ITATIBANT | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 39 | Boc-sar-oh | 13734-36-6) | Saralanan | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 40 | Fmoc-sar-oh | 77128--70-2 | Saralanan | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 41 | Fmoc-tyr (so3na) -oh.h2o | 106864-37-3 | Sincalide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 42 | Fmoc-d-asp (Otbu) -oh | 112883-39-3 | Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 43 | Ac-ser (tbu) -oh | 77285-09-7 | AfAmenotidede | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
| 44 | Boc-Homocys (Trt) - | 201419-16-1 | Potlako | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 45 | Fmoc-homocys (trt) -oh | 167015-23-8 | Potlako | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 46 | Fmoc-dab-oh | 161420-87-7-7 | Nono ea noha | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
* Max1 = Mamela a sa tsejoe a sa tsejoe
Letšoao le leng:
- acid acid: ≤0.02% (lihlahisoa tsohle)
- Ethyl acetate: ≤0.5% (lihlahisoa tsohle)
- Joala: ≤0.5% (lihlahisoa tsohle)
- Ho se tsebe letho: fmoc-tlelep (boc) -oh (143824-78-6) ≤0.3%; Ba bang ≤0.2%
